Search Tag: COVID-19 vaccine
2024 10 May
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards Provides Novavax with cash and an equity investment totalling approximately $1.2 billion (upfront payment of $500 million and up to $700 million in additional development, regulatory...Read more
2022 19 Jun
The Food and Drug Administration (FDA) has given emergency use authorisation to the Pfizer/BioNTech and Moderna vaccines for children under five. Vaccine advisors at the CDC have voted unanimously in support of the measure. As a result, the COVID-19 vaccine can now be given to children as young as six months old. The Pfizer vaccine is good for...Read more
2021 19 Oct
On Friday, 15 October, a U.S. FDA advisory committee unanimously recommended that all adults that received the Johnson & Johnson (J&J) COVID-19 vaccine get a booster shot at least two months after their first shot. J&J now joins Pfizer and Moderna in gaining an FDA recommendation for a booster. Unlike the Pfizer and Moderna recommendations which...Read more
2021 22 Sep
In July, New York University researchers published results (Tada et. al, 2021) indicating the one-shot Johnson & Johnson (J&J) vaccine was less effective at preventing Delta variant infections. Although the study is not yet peer-reviewed, this finding is troubling given that the Delta variant now accounts for most US COVID-19 cases. Booster doses were...Read more
2021 21 Sep
Given that children and adolescents can get sick with COVID-19, attending K-12 schools in-person remains a risk. According to the American Academy of Pediatrics, children accounted for 25.7% of US cases for the week of 16 September (American Academy of Pediatrics, 2021), while hospitalisations averaged 311 children/day (Centers for Disease Control...Read more
2021 27 Jul
The Delta variant of the SARS-CoV-2 virus that causes COVID-19 has contributed to a significant surge in cases around the globe, including India and the U.K. While more and more people continue to get vaccinated worldwide, the effectiveness of these vaccines against the delta variant remains unclear. In this study, researchers use a negative-case...Read more
2021 08 Jun
People around the world are getting the COVID-19 vaccine. There are four main options out there for those who want to be vaccinated - the Pfizer-BioNTech vaccine, the Moderna vaccine, the on-and-off Astra Zeneca vaccine and the single-dose Johnson & Johnson vaccine. While most people are optimistic that mass vaccination will help the world...Read more
2021 26 May
While overall COVID-19 cases and deaths have fallen worldwide over the past few weeks, the threat from the now 18-month pandemic has not passed and the world remains in a dangerous situation, according to the director-general of the World Health Organization. "No country should assume it is out of the woods, no matter its vaccination rate,"...Read more
2021 11 May
A COVID-19 vaccine centre has been set up at Dracula's castle in Transylvania. Healthcare professionals with fang stickers on their scrubs are providing Pfizer shots to everyone who visits Bran Castle in central Romania. The goal of operating a vaccination clinic on this site is to encourage Romanians to get the vaccine. Compared to global numbers,...Read more
2021 25 Mar
In a sudden turnabout, German Chancellor Angela Merkel, announced on Wednesday that the country will not go into a strict lockdown over Easter in order to try and break a third Covid-19 wave. After a backlash from the weary public, the Chancellor withdrew the measure. A new lockdown would have meant that all stores, including food and essentials,...Read more
2021 11 Mar
The European Medicines Agency’s (EMA) announced today that the single dose Covid-19 vaccine has been approved for use in individuals 18 years of age and older in the European Union. Developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) in Belgium and the Netherlands, this vaccine is the fourth to be approved by the EMA....Read more
2021 05 Mar
The vaccine manufacturer Moderna and IBM, a technology company, will work together on implementation of technologies such as artificial intelligence, blockchain and hybrid cloud, to improve COVID-19 vaccine management in the U.S. You might also like: An interview with European and U.S. e xperts about the need for global...Read more
2021 02 Mar
People across the world heaved a sigh of relief when the first COVID-19 vaccine was approved. But, as is human nature, happy news is typically followed by debate, controversy, ifs and buts and what-nots. The COVID-19 vaccine is no different. As the distribution of Pfizer-BioNTech and the Moderna vaccines began across the world, so did the debate...Read more